Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma
Abstract
Here, primary effusion lymphoma (PEL) is a rare large B-cell neoplasm particularly affecting immunodeficient hosts with an increased incidence in young or middle-aged males infected with the HIV.1 The clinical outcome of patients with PEL is unfavorable with a median survival of <6 months.1 PEL has been closely associated with human herpes virus 8 (HHV8, previously called Kaposi sarcoma herpesvirus) infection.1 In some cases a coinfection of HHV8 with the Epstein–Barr Virus (EBV) has been described.1 HHV8 encodes various genes homologous to cellular genes that have proliferative and anti-apoptotic functions.2 Although HHV8 is supposed to be a major driver of PEL, it alone is not sufficient for a full-blown lymphomagenesis.2 PEL usually shows complex karyotypes with many chromosomal aberrations.3 This chromosomal complexity might be driven by the viral infection and lead to genetic alterations cooperating with HHV8 in PEL lymphomagenesis.4
- Authors:
-
- Univ. Hospital Schleswig-Holstein, Christian-Albrechts-Univ., Kiel (Germany)
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Univ. Hospital of Cologne, Cologne (Germany)
- Deutsches Krebsforschungszentrum Heidelberg (DKFZ), Heidelberg (Germany)
- Leibniz-Institute DSMZ, Braunschweig (Germany)
- Wellcome Trust Cancer Sanger Institute, Hinxton (United Kingdom)
- Publication Date:
- Research Org.:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1248630
- Report Number(s):
- LA-UR-15-20054
Journal ID: ISSN 0887-6924; leu201522
- Grant/Contract Number:
- AC52-06NA25396
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Leukemia
- Additional Journal Information:
- Journal Volume: 29; Journal Issue: 7; Journal ID: ISSN 0887-6924
- Publisher:
- Nature Publishing Group (NPG)
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., and Siebert, R. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. United States: N. p., 2015.
Web. doi:10.1038/leu.2015.22.
Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., & Siebert, R. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. United States. https://doi.org/10.1038/leu.2015.22
Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., and Siebert, R. Wed .
"Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma". United States. https://doi.org/10.1038/leu.2015.22. https://www.osti.gov/servlets/purl/1248630.
@article{osti_1248630,
title = {Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma},
author = {Wagener, R. and Alexandrov, L. B. and Montesinos-Rongen, M. and Schlesner, M. and Haake, A. and Drexler, H. G. and Richter, J. and Bignell, G. R. and McDermott, U. and Siebert, R.},
abstractNote = {Here, primary effusion lymphoma (PEL) is a rare large B-cell neoplasm particularly affecting immunodeficient hosts with an increased incidence in young or middle-aged males infected with the HIV.1 The clinical outcome of patients with PEL is unfavorable with a median survival of <6 months.1 PEL has been closely associated with human herpes virus 8 (HHV8, previously called Kaposi sarcoma herpesvirus) infection.1 In some cases a coinfection of HHV8 with the Epstein–Barr Virus (EBV) has been described.1 HHV8 encodes various genes homologous to cellular genes that have proliferative and anti-apoptotic functions.2 Although HHV8 is supposed to be a major driver of PEL, it alone is not sufficient for a full-blown lymphomagenesis.2 PEL usually shows complex karyotypes with many chromosomal aberrations.3 This chromosomal complexity might be driven by the viral infection and lead to genetic alterations cooperating with HHV8 in PEL lymphomagenesis.4},
doi = {10.1038/leu.2015.22},
journal = {Leukemia},
number = 7,
volume = 29,
place = {United States},
year = {Wed Feb 04 00:00:00 EST 2015},
month = {Wed Feb 04 00:00:00 EST 2015}
}
Web of Science
Works referenced in this record:
Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities
journal, January 2002
- Wilson, Kathleen S.; McKenna, Robert W.; Kroft, Steven H.
- British Journal of Haematology, Vol. 116, Issue 1
Primary Body Cavity-Based AIDS-Related Lymphomas
journal, February 1996
- Ansari, M. Qasim; Dawson, D. Brian; Nador, Roland
- American Journal of Clinical Pathology, Vol. 105, Issue 2
The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
journal, January 2013
- Vieira, Valdimara C.; Soares, Marcelo A.
- BioMed Research International, Vol. 2013
Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
journal, June 2011
- Suspene, R.; Aynaud, M. -M.; Koch, S.
- Journal of Virology, Vol. 85, Issue 15
APOBEC3B is an enzymatic source of mutation in breast cancer
journal, February 2013
- Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.
- Nature, Vol. 494, Issue 7437
Signatures of mutational processes in human cancer
journal, August 2013
- Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
- Nature, Vol. 500, Issue 7463
BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability
journal, April 1998
- Brimmell, Matthew; Mendiola, Rezzeline; Mangion, Jonathan
- Oncogene, Vol. 16, Issue 14
Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association
journal, December 2004
- Fan, W.; Bubman, D.; Chadburn, A.
- Journal of Virology, Vol. 79, Issue 2
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts
journal, January 2003
- Klein, U.
- Blood, Vol. 101, Issue 10
Reverse engineering of regulatory networks in human B cells
journal, March 2005
- Basso, Katia; Margolin, Adam A.; Stolovitzky, Gustavo
- Nature Genetics, Vol. 37, Issue 4
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus
journal, June 2004
- Hong, Young-Kwon; Foreman, Kimberly; Shin, Jay W.
- Nature Genetics, Vol. 36, Issue 7
Functional Genomic Relationships in HIV‐1 Disease Revealed by Gene‐Expression Profiling of Primary Human Peripheral Blood Mononuclear Cells
journal, June 2005
- Ockenhouse, Christian F.; Bernstein, Wendy B.; Wang, Zhining
- The Journal of Infectious Diseases, Vol. 191, Issue 12
Microarray Analysis of Lymphatic Tissue Reveals Stage-Specific, Gene Expression Signatures in HIV-1 Infection
journal, July 2009
- Li, Qingsheng; Smith, Anthony J.; Schacker, Timothy W.
- The Journal of Immunology, Vol. 183, Issue 3
Signatures of mutational processes in human cancer.
text, January 2013
- Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C.
- Apollo - University of Cambridge Repository
Works referencing / citing this record:
Clock-like mutational processes in human somatic cells
journal, November 2015
- Alexandrov, Ludmil B.; Jones, Philip H.; Wedge, David C.
- Nature Genetics, Vol. 47, Issue 12
The effects of mutational processes and selection on driver mutations across cancer types
journal, May 2018
- Temko, Daniel; Tomlinson, Ian P. M.; Severini, Simone
- Nature Communications, Vol. 9, Issue 1
Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
journal, April 2019
- Matsutani, Taro; Ueno, Yuki; Fukunaga, Tsukasa
- Bioinformatics, Vol. 35, Issue 22
Understanding mutagenesis through delineation of mutational signatures in human cancer
journal, May 2016
- Petljak, Mia; Alexandrov, Ludmil B.
- Carcinogenesis, Vol. 37, Issue 6
Mutational signatures associated with tobacco smoking in human cancer
journal, November 2016
- Alexandrov, L. B.; Ju, Y. S.; Haase, K.
- Science, Vol. 354, Issue 6312
Biology and management of primary effusion lymphoma
journal, November 2018
- Shimada, Kazuyuki; Hayakawa, Fumihiko; Kiyoi, Hitoshi
- Blood, Vol. 132, Issue 18
Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma
journal, August 2018
- Liu, Fang; Wang, Zhe; Zhou, Xiaoge
- PLOS ONE, Vol. 13, Issue 8
Mutational signatures associated with tobacco smoking in human cancer
posted_content, May 2016
- Alexandrov, Ludmil B.; Ju, Young Seok; Haase, Kerstin
- bioRxiv
The effects of mutational processes and selection on driver mutations across cancer types
posted_content, June 2017
- Temko, Daniel; Tomlinson, Ian P. M.; Severini, Simone
- bioRxiv
Author Correction: The effects of mutational processes and selection on driver mutations across cancer types
journal, April 2020
- Temko, Daniel; Tomlinson, Ian P. M.; Severini, Simone
- Nature Communications, Vol. 11, Issue 1
Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
journal, April 2019
- Matsutani, Taro; Ueno, Yuki; Fukunaga, Tsukasa
- Bioinformatics, Vol. 35, Issue 22
Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma
journal, August 2018
- Liu, Fang; Wang, Zhe; Zhou, Xiaoge
- PLOS ONE, Vol. 13, Issue 8
The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
journal, November 2017
- Volinia, Stefano; Druck, Teresa; Paisie, Carolyn A.
- Oncotarget, Vol. 8, Issue 60